Saxsons Group — India's trusted nuclear medicine, radiotherapy, oncosurgery, dosimetry and cyclotron supplier since 1986

All research papers

2996 approved papers, newest first · showing 301–360.Search instead →

  1. 18 Sept 2026· Journal of Cancer· Lu-177 FAPI· Diagnostic· Free full text
    Per-patient Comparison of [<sup>68</sup>Ga]-FAPI-46 Versus [<sup>18</sup>F]FDG as PET Tracers in ER-positive Breast Cancer: Study Design of a Single-centre Prospective Study.
    Lenaerts M et al.
  2. 18 Sept 2026· Nuclear medicine and biology· Cyclotron production· Radiopharmacy· Diagnostic
    Automated clinical production, dosimetry estimates and preclinical safety considerations for clinical translation of a SOAT1-targeted PET imaging agent.
    Kaup G et al.
  3. 18 Sept 2026· Sensors (Basel, Switzerland)· OSL dosimetry· QA & dosimetry
    LuminaOSL: Development and Experimental Validation of a Modular Automated Platform for Optically Stimulated Luminescence Measurements.
    Karsu Asal EC et al.
  4. 18 Sept 2026· Advances in radiation oncology· SBRT delivery· Therapeutic
    Evaluation of Cardiac Function After Stereotactic Body Radiation Therapy for Lung Tumors: Results of the Prospective Explorative Heart-Lung Study.
    Hoeksema WF et al.
  5. 18 Sept 2026· Auris, nasus, larynx· I-131 therapy· Therapeutic
    Molecular targeted therapy for thyroid cancer in Japan: Current status and future perspectives.
    Moritani S.
  6. 18 Sept 2026· Biology of sex differences· I-131 therapy· Therapeutic· Free full text
    Sex and age at exposure influence <sup>131</sup>I biodistribution and dosimetry in Sprague-Dawley rats.
    Schroff A et al.
  7. 18 Sept 2026· Journal of neuro-oncology· SRS / intracranial· Therapeutic· Free full text
    Reirradiation outcomes following salvage conventionally fractionated Gamma Knife stereotactic radiotherapy (SFGK) to recurrent primary non-glial brain tumors.
    Udovicich C et al.
  8. 18 Sept 2026· Journal of applied clinical medical physics· SRS / intracranial· QA & dosimetry· Free full text
    Evaluation of interfractional shift corrections in Gamma Knife radiosurgery
    Opalko E et al.
  9. 18 Sept 2026· Journal of applied clinical medical physics· Patient-specific QA· QA & dosimetry· Free full text
    Commissioning and end‐to‐end validation of a combined surface‐guided and triggered kV imaging workflow for breath‐hold SBRT on a Varian TrueBeam
    Osunkwor O et al.
  10. 18 Sept 2026· Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)· Adaptive radiotherapy· QA & dosimetry· Therapeutic· Free full text
    Feasibility of prostate offline adaptive radiation therapy using iterative reconstructed CBCT to optimize the ART workflow.
    Vicedo González MA et al.
  11. 18 Sept 2026· Cancer science· SBRT delivery· Therapeutic· Free full text
    Advances in Radiotherapy for Neoadjuvant Therapy of Stage III Non-Small Cell Lung Cancer.
    Mao Q et al.
  12. 18 Sept 2026· Academic radiology· Ga-68 DOTATATE· Diagnostic· Free full text
    Predicting Response to Somatostatin Analog Therapy in GEP-NET Liver Metastases: A Machine Learning Approach with ⁶⁸Ga-DOTATATE and ¹⁸F-FDG PET/CT.
    Xu J et al.
  13. 18 Sept 2026· BMJ open· Ga-68 PSMA PET· Diagnostic· Free full text
    Can early ⁶⁸Ga-PSMA-11 PET/CT predict 6-month disease control in patients receiving first-line systemic therapy for metastatic clear-cell renal cell carcinoma? Protocol for the multicentre prospective phase II PSMA-RENAL study in Belgium.
    Seront E et al.
  14. 18 Sept 2026· Cureus· SBRT delivery· Therapeutic· Free full text
    Palliative Stereotactic Body Radiotherapy for Metastatic Clear Cell Sarcoma: A Case Report
    Mizumatsu S et al.
  15. 18 Sept 2026· Frontiers in immunology· SRS / intracranial· Therapeutic· Free full text
    Complete and durable remission in a patient with brain metastasis from gastric cancer treated with SRS followed by RC48 plus camrelizumab after progression on chemo-immunotherapy: a case report and literature review
    Liu X et al.
  16. 18 Sept 2026· Frontiers in oncology· SRS / intracranial· Therapeutic· Free full text
    Surgical resection with postoperative stereotactic radiosurgery versus stereotactic radiosurgery alone for large (>3 cm) multiple brain metastases: a propensity score-matched analysis
    Guo X et al.
  17. 18 Sept 2026· Frontiers in oncology· Breast / lung positioning· QA & dosimetry· Free full text
    Beyond the snapshot: continuous optical surface monitoring reveals non-linear temporal dynamics and postural stability window in free-breathing breast radiotherapy
    Huang W et al.
  18. 18 Sept 2026· Frontiers in cell and developmental biology· Radiation safety· Free full text
    Early diagnosis of radiation-induced renal injury: from lagging indicators to multimodal, pre-fibrotic detection
    Zhang Y et al.
  19. 17 Sept 2026· Frontiers in oncology· Breast / lung positioning· Therapeutic· Free full text
    Surface-guided deep-inspiration breath-hold radiotherapy for left-sided breast cancer: a systematic review and meta-analysis of dosimetric outcomes and image-verified setup accuracy.
    Wu X et al.
  20. 17 Sept 2026· Physics and imaging in radiation oncology· Breast / lung positioning· Therapeutic· Free full text
    Improved chest wall stability during deep-inspiration breath-hold in breast cancer radiotherapy following quality improvement initiatives.
    Høgsbjerg KW et al.
  21. 17 Sept 2026· Frontiers in oncology· SBRT delivery· Therapeutic· Free full text
    Transcatheter arterial chemoembolization combined with stereotactic body radiation therapy versus transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis.
    Zeng D et al.
  22. 17 Sept 2026· World journal of urology· Ga-68 PSMA PET· Diagnostic· Free full text
    Safety and patient-reported outcomes of multimodal PSMA PET/MRI-guided prostate biopsy: results from the prospective multicenter DEPROMP trial.
    Schmidt CJ et al.
  23. 17 Sept 2026· Applied radiation and isotopes· OSL dosimetry· QA & dosimetry
    Preliminary feasibility results for implementing a phantom model for external auditing of HDR brachytherapy with an Ir-192 HDR source: an IAEA collaborative project.
    Briggs N et al.
  24. 17 Sept 2026· Cancers· Adaptive radiotherapy· Therapeutic· Free full text
    Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy in Lung Cancer and Lung Metastases: A Systematic Review.
    Zidan A et al.
  25. 17 Sept 2026· Journal of nuclear medicine· Cyclotron production· Therapeutic· Radiopharmacy
    Beta Atlas: Charting Global Production of Nonconventional β--Emitters for Targeted Radiopharmaceutical Therapy-Part 1.
    Tosato M et al.
  26. 17 Sept 2026· Physica medica· TLD dosimetry· Radiation safety
    Dosimetry with LIF:Mg,Ti (TLD-100) for locating non-paubable breast cancer using Iodine-125 seeds.
    Santos HN et al.
  27. 17 Sept 2026· Cancer treatment and research communications· Ra-223· Therapeutic
    Radium-223 alters the levels of soluble immune regulators in the plasma of patients with metastatic castrate-resistant prostate cancer.
    S L et al.
  28. 17 Sept 2026· The EANM Journal· Diagnostic· Therapeutic· Free full text
    Regulatory and organisational barriers to non-commercial clinical trials in European nuclear medicine: Results from an EANM survey
    Matteo Bauckneht et al.
  29. 17 Sept 2026· Indian journal of cancer· Thermoplastic masks· Therapeutic· Free full text
    Use of a novel tongue-sparing intraoral prosthesis for radiation therapy in a head and neck patient: A case report.
    Pandey VK et al.
  30. 17 Sept 2026· Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)· QA & dosimetry· Free full text
    Clinical applications of the Halcyon O-ring linear accelerator in radiation therapy: a systematic review of treatment efficacy, workflow efficiency, and imaging integration.
    Duong TT et al.
  31. 17 Sept 2026· Journal of medical imaging and radiation sciences· SBRT delivery· Therapeutic· QA & dosimetry· Free full text
    Dosimetric impact of coplanar and non-coplanar arc arrangements in VMAT-based lung SABR.
    Özer S et al.
  32. 17 Sept 2026· Molecular imaging and biology· Ac-225 alpha therapy· Theranostic· Therapeutic· Free full text
    Proof-of-Concept of CAIX-Targeted α-Particle Delivery in a Patient-Derived Hypoxic Head and Neck Squamous Cell Carcinoma Model.
    Wenker STM et al.
  33. 17 Sept 2026· Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)· Ga-68 DOTATATE· Diagnostic· QA & dosimetry· Free full text
    EARL-based quantitative evaluation of administered activity reduction for [⁶⁸Ga]Ga-DOTATOC PET/CT on a 32-cm axial FOV digital BGO system: Phantom analysis and retrospective list-mode clinical assessment.
    Piai A et al.
  34. 17 Sept 2026· Cancer biotherapy & radiopharmaceuticals· Lu-177 FAPI· Theranostic· Therapeutic· Free full text
    Theranostic Radiopharmaceutical-Guided Robotic Surgery for Precision Tumor Resection and Targeted Elimination of Residual Disease in Digestive System Malignancies.
    Wen Y et al.
  35. 17 Sept 2026· Frontiers in medicine· Ga-68 DOTATATE· Theranostic· Diagnostic· Free full text
    Editorial: Recent advances in theranostics: endocrine tumours and beyond
    Nieri A et al.
  36. 16 Sept 2026· Cureus· SBRT delivery· Therapeutic
    Spontaneous Pneumothorax During Stereotactic Body Radiotherapy for Pulmonary Metastasis From Osteosarcoma: A Case Report and Literature Review.
    Kumar V et al.
  37. 16 Sept 2026· Cureus· Ga-68 PSMA PET· Diagnostic
    Gallium-68 (68Ga)-Labelled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Initial Staging of High-Risk Prostatic Adenocarcinoma: Reclassification to Oligometastatic Disease and Change in Treatment Intent.
    Villalba-Meneses CP et al.
  38. 16 Sept 2026· Frontiers in oncology· Adaptive radiotherapy· Therapeutic· Free full text
    Case Report: Acute prostatic swelling following hydrogel spacer insertion managed by MR-guided online adaptive radiotherapy.
    Takahashi Y et al.
  39. 16 Sept 2026· Abdominal radiology (New York)· Ga-68 PSMA PET· Diagnostic
    Limited incremental prognostic value of pretreatment MRI and <sup>18</sup>F-piflufolastat PET intensity metrics in grade group ≥ 3 prostate cancer.
    Aleenajitpong N et al.
  40. 16 Sept 2026· European radiology· Ga-68 PSMA PET· Diagnostic
    Prognostic value of baseline PSMA PET/CT for survival in synchronous metastatic hormone-sensitive prostate cancer: towards redefining low- and high-volume disease.
    Kleiburg F et al.
  41. 16 Sept 2026· Journal of clinical medicine· Patient-specific QA· QA & dosimetry· Free full text
    Assessing Gamma Index Sensitivity to Selected Linear Accelerator Mechanical Errors Using Various Dosimetric Systems.
    Ayata HB et al.
  42. 16 Sept 2026· Expert opinion on pharmacotherapy· Ga-68 DOTATATE· Diagnostic· Therapeutic
    New and emerging somatostatin therapies for neuroendocrine tumors: "what is in the pipeline".
    Lee L et al.
  43. 16 Sept 2026· Physics in Medicine and Biology· QA & dosimetry· Free full text
    Pulse width-dependent Monte Carlo source modelling for ultra-high dose rate electron beams
    Angela Maria Henao Isaza et al.
  44. 16 Sept 2026· Cancer metastasis reviews· QA & dosimetry· Free full text
    Circulating Cell-free DNA as a biomarker for radiation-induced injury: From mechanistic insights to clinical translation.
    Sun Q et al.
  45. 16 Sept 2026· Cancer research and treatment· SBRT delivery· Therapeutic· Free full text
    Ablative SABR for Pulmonary Oligometastases in the Era of Contemporary Systemic Therapies: Efficacy, Safety, and Optimal Sequencing.
    Shin H et al.
  46. 16 Sept 2026· Medical physics· QA & dosimetry· Free full text
    AAPM Task Group 66U1 report 83.B: Quality assurance for computed‐tomography simulators in radiation oncology
    Cammin J et al.
  47. 16 Sept 2026· BMC cancer· Lu-177 DOTATATE· Therapeutic· Free full text
    Profiling proteomic responses in small intestinal neuroendocrine tumor GOT1 after [¹⁷⁷Lu]Lu-DOTATATE therapy.
    Spetz JKE et al.
  48. 16 Sept 2026· Lu-177 PSMA· Therapeutic· Free full text
    Dynamics of circulating tumor cell subsets defined by PSMA and EpCAM predict survival in metastatic castration-resistant prostate cancer patients treated with 177Lu-PSMA-617
    Lee MJ et al.
  49. 16 Sept 2026· Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)· Adaptive radiotherapy· QA & dosimetry· Therapeutic· Free full text
    Adaptive radiation therapy for anatomical changes of the breast during whole-breast irradiation.
    Lim S et al.
  50. 16 Sept 2026· Journal of neuroradiology = Journal de neuroradiologie· SRS / intracranial· Therapeutic· Free full text
    Minimal Target Embolization of High-Risk Component in Brain Arteriovenous Malformation Combined with Stereotactic Radiosurgery: a Proof-of-Concept Study.
    Koizumi S et al.
  51. 16 Sept 2026· JCEM case reports· I-131 therapy· Diagnostic· Therapeutic· Free full text
    EML4::RET, a novel transcript fusion in papillary thyroid cancer
  52. 16 Sept 2026· Dementia & neuropsychologia· Diagnostic· Free full text
    Cerebral oxygen extraction fraction as an emerging imaging biomarker in mild cognitive impairment and dementia A fração de extração de oxigênio cerebral como um biomarcador de imagem emergente no comprometimento cognitivo leve e na demência
    Hussain J et al.
  53. 16 Sept 2026· Open Medicine· Therapeutic· Free full text
    Follow-up–dependent calendar-period associations with cardiac mortality after lung cancer radiotherapy: a competing-risks SEER analysis
    Zhang N et al.
  54. 16 Sept 2026· Frontiers in nuclear medicine· Diagnostic· Free full text
    Quantification in bone SPECT/CT
    Zivanovic J et al.
  55. 15 Sept 2026· Frontiers in oncology· Adaptive radiotherapy· Therapeutic· Free full text
    Case Report: MR-guided adaptive stereotactic body radiotherapy for splenic metastases: a case series of technical feasibility and early clinical outcomes.
    Tan D et al.
  56. 15 Sept 2026· Radiotherapy and oncology· SBRT delivery· QA & dosimetry· Therapeutic
    Lessons learned from the multicentre QA program in SBRT for perihilar cholangiocarcinoma: benchmark-case results from the STRONG II trial.
    van Loosbroek SY et al.
  57. 15 Sept 2026· European journal of nuclear medicine and molecular imaging· Ga-68 PSMA PET· Diagnostic
    Development and validation of a preoperative <sup>18</sup>F-PSMA-1007 PET/MR prognostic model for predicting biochemical recurrence in prostate cancer: a multicentre study.
    Hu J et al.
  58. 15 Sept 2026· European journal of nuclear medicine and molecular imaging· Ga-68 PSMA PET· Diagnostic
    Tri-modal PSMA PET/CT-MRI-US fusion biopsy for clinically significant prostate cancer: a prospective paired diagnostic study.
    Huang C et al.
  59. 15 Sept 2026· Oncology letters· SRS / intracranial· Therapeutic· Free full text
    Optimal timing of stereotactic radiosurgery with first-line osimertinib in EGFR-mutant non-small cell lung cancer brain metastases: Immediate, early-consolidation and salvage strategies.
    Zhuang X et al.
  60. 15 Sept 2026· Clinical and translational radiation oncology· SBRT delivery· Therapeutic
    Hypofractionated and stereotactic body proton radiotherapy for a high-risk lung cancer cohort: A multi-institutional experience from the proton collaborative group prospective registry.
    Allen AJ et al.